Iqvia Holdings (IQV) Total Non-Current Liabilities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Total Non-Current Liabilities came in at $22.7 billion in Q1 2026, up 9.91% year-on-year from $20.7 billion in Q1 2025, and little changed quarter-over-quarter from $22.6 billion in Q4 2025.
Iqvia Holdings (IQV) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Total Non-Current Liabilities across 15 years of filings, most recently posting $22.7 billion for Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $22.7 billion, up 9.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.7 billion (up 9.91% YoY), and the FY2025 annual result was $22.6 billion, up 12.21% from the prior year.
- Total Non-Current Liabilities came in at $22.7 billion for Q1 2026 at Iqvia Holdings, roughly flat from $22.6 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $22.7 billion in Q1 2026 to a low of $18.3 billion in Q3 2022.
- The 5-year median for Total Non-Current Liabilities is $19.6 billion (2024), against an average of $20.1 billion.
- Across the five-year window, Total Non-Current Liabilities dropped 2.72% in 2024 and climbed 16.39% in 2025, its largest moves.
- Iqvia Holdings' Total Non-Current Liabilities stood at $19.4 billion in 2022, then advanced by 2.43% to $19.9 billion in 2023, then climbed by 1.47% to $20.2 billion in 2024, then rose by 12.21% to $22.6 billion in 2025, then rose by 0.37% to $22.7 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $22.7 billion (Q1 2026), $22.6 billion (Q4 2025), and $21.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 8.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.71 Bn |
| Dec 31, 2025 | 22.63 Bn |
| Sep 30, 2025 | 21.74 Bn |
| Jun 30, 2025 | 22.18 Bn |
| Mar 31, 2025 | 20.66 Bn |
| Dec 31, 2024 | 20.16 Bn |
| Sep 30, 2024 | 19.60 Bn |
| Jun 30, 2024 | 19.05 Bn |
| Mar 31, 2024 | 19.64 Bn |
| Dec 31, 2023 | 19.87 Bn |
| Sep 30, 2023 | 19.49 Bn |
| Jun 30, 2023 | 19.59 Bn |
| Mar 31, 2023 | 19.17 Bn |
| Dec 31, 2022 | 19.40 Bn |
| Sep 30, 2022 | 18.32 Bn |
| Jun 30, 2022 | 18.50 Bn |
| Mar 31, 2022 | 18.47 Bn |
| Dec 31, 2021 | 18.57 Bn |
| Sep 30, 2021 | 18.11 Bn |
| Jun 30, 2021 | 18.09 Bn |